Cart
sales@molnova.com
2:PN:US20040072744 SEQID:2 claimed protein
CAS No. 389572-87-6
2:PN:US20040072744 SEQID:2 claimed protein( —— )
Catalog No. M29969 CAS No. 389572-87-6
2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 3645 | Get Quote |
|
| 10MG | 6156 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2:PN:US20040072744 SEQID:2 claimed protein
-
NoteResearch use only, not for human use.
-
Brief Description2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
-
Description2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number389572-87-6
-
Formula Weight1070.13
-
Molecular FormulaC43H67N13O17S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Asn-Leu-Gly-Glu-His-Pro-Val-Cys-Asp-Ser
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Synthetic peptide as treatment for Down's syndrome and schizophrenia.
molnova catalog
related products
-
DLinDMA
DLinDMA, as a benchmark, is a key stable nucleic acid lipid particleslipid component.
-
PF-06952229
PF-06952229 is an selective and orally active inhibitor of TGFbR1.
-
Oblongine
Oblongine chloride may have potential haemodynamic effects, it can cause a dose-dependent reduction of systolic and diastolic blood pressure, and that these effects are not mediated by α2-adrenergic receptor stimulation.
